Effect of sodium caprate on the oral absorptions of danshensu and salvianolic acid B

International Journal of Pharmaceutics

Volumn 379, Issue 1-2, 2009, Pages 109-118

  Zhou, Limin ^a   Chow, Moses S S ^a,b   Zuo, Zhong ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Absorption enhancer; Bioavailability; Danshensu; Intestinal absorption; Salvianolic acid B; Sodium caprate

Indexed keywords

3 (3,4 DIHYDROXYPHENYL)LACTIC ACID; ATENOLOL; DECANOATE SODIUM; PENETRATION ENHANCING AGENT; SALVIANOLIC ACID B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; CYTOTOXICITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG STABILITY; DRUG STRUCTURE; HALF LIFE TIME; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANIMALS; BENZOFURANS; BIOLOGICAL AVAILABILITY; CACO-2 CELLS; DECANOIC ACIDS; EXCIPIENTS; HUMANS; INTESTINAL ABSORPTION; LACTATES; MALE; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; SALVIA MILTIORRHIZA;

EID: 68749116199     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.06.016     Document Type: Article

References (48)

1. Anderberg E.K., Lindmark T., and Artursson P. Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route. Pharm. Res. 10 (1993) 857-864
2. Aungst B.J. Intestinal permeation enhancers. J. Pharm. Sci. 89 (2000) 429-442
3. Cao J., Wei Y.J., Qi L.W., Li P., Qian Z.M., Luo H.W., Chen J., and Zhao J. Determination of fifteen bioactive components in Radix Rhizoma Salviae Miltiorrhizae by high-performance liquid chromatography with ultraviolet and mass spectrometric detection. Biomed. Chromatogr. 22 (2008) 164-172
4. Chan K., Chui S.H., Wong D.Y., Ha W.Y., Chan C.L., and Wong R.N. Protective effects of danshensu from the aqueous extract of Salvia miltiorrhiza (Danshen) against homocysteine-induced endothelial dysfunction. Life Sci. 75 (2004) 3157-3171
5. Chang Q., Zuo Z., Ho W.K., and Chow M.S. Comparison of the pharmacokinetics of hawthorm phenolics in extract versus individual pure compound. J. Clin. Pharmacol. 45 (2005) 106-112
6. Chao A.C., Nguyen J.V., Broughall M., Griffin A., Fix J.A., and Daddona P.E. In vitro and in vivo evaluation of effects of sodium caprate on enteral peptide absorption and on mucosal morphology. Int. J. Pharm. 191 (1999) 15-24
7. Grès M.C., Julian B., Bourrié M., Meunier V., Roques C., Berger M., Boulenc X., Berger Y., and Fabre G. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. Pharm. Res. 15 (1998) 726-733
8. Guo Z.X., Jia W., Gao W.Y., Xu Z.H., Zhao L.B., and Xiao P.G. Clinical investigation of composite Danshen Dripping Pill for the treatment of angina pectoris. Zhongguo Tianran Yaowu 1 (2003) 124-128
9. Hong X., Mi S.Q., and Wang N.S. Pharmacokinetics study of danshensu in compound Danshen Dripping Pill. Zhongyao Xinyao yu Linchuang Yaoli 11 (2000) 286-288
10. Jonker C., Hamman J.H., and Kotzé A.F. Intestinal paracellular permeation enhancement with quaternised chitosan: in situ and in vitro evaluation. Int. J. Pharm. 238 (2002) 205-213
11. Kang D.G., Oh H., Sohn E.J., Hur T.Y., Lee K.C., Kim K.J., Kim T.Y., and Lee H.S. Lithospermic acid B isolated from Salvia miltiorrhiza ameliorates ischemia/reperfusion-induced renal injury in rats. Life Sci. 75 (2004) 1801-1816
12. Kim H.H., Kim J., Ji H.Y., Kim Y.C., Sohn D.H., Lee B.M., and Lee H.S. Pharmacokinetics of lithospermic acid B isolated from Salvia miltiorrhiza in rats. J. Toxicol. Environ. Health A. 68 (2005) 2239-2247
13. Li C.Z., Yang S.C., Zhao F.D., Yang Y.Q., Yang C.X., and Zhang D.C. Anticoagulant studies of Danshen. Zhongxiyi Jiehe Zazhi 3 (1983) 297-299
14. Li M., Zhao C., Wong R.N., Goto S., Wang Z.M., and Liao F.L. Inhibition of shear-induced platelet aggregation in rat by tetramethylpyrazine and salvianolic acid B. Clin. Hemorheol. Microcirc. 31 (2004) 97-103
15. Li W., Li Z.W., Han J.P., Li X.X., Gao J., and Liu C.X. Determination and pharmacokinetics of danshensu in rat plasma after oral administration of danshen extract using liquid chromatography/tandem mass spectrometry. Eur. J. Drug Metab. Pharmacokinet. 33 (2008) 9-16
16. Li X., Yu C., Lu Y., Gu Y., Lu J., Xu W., Xuan L., and Wang Y. Pharmacokinetics, tissue distribution, metabolism, and excretion of depside salts from Salvia miltiorrhiza in rats. Drug Metab. Dispos. 35 (2007) 234-239
17. Lindmark T., Schipper N., Lazorová L., de Boer A.G., and Artursson P. Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: assessment of molecular weight dependence and demonstration of transport routes. J. Drug Target. 5 (1998) 215-223
18. Liu M., Li Y.G., Zhang F., Yang L., Chou G.X., Wang Z.T., and Hu Z.B. Chromatographic fingerprinting analysis of Danshen root (Salvia miltiorrhiza Radix et Rhizoma) and its preparations using high performance liquid chromatography with diode array detection and electrospray mass spectrometry (HPLC-DAD-ESI/MS). J. Sep. Sci. 30 (2007) 2256-2267
19. Liu X.Q., Luo X.T., and Ouyang X.A. Research advance of Fufang Danshen dosage forms. Shizhen Guoyi Guoyao 12 (2001) 474-475
20. Luo X.J., Bi K.S., Zhou S.Y., Wei Q.H., and Zhang R.H. Determination of danshensu, a major active compound of Radix Salvia miltiorrhiza in dog plasma by HPLC with fluorescence detection. Biomed. Chromatogr. 15 (2001) 493-496
21. Ma H.L., Qin M.J., Qi L.W., Wu G., and Shu P. Improved quality evaluation of Radix Salvia miltiorrhiza through simultaneous quantification of seven major active components by high-performance liquid chromatography and principal component analysis. Biomed. Chromatogr. 21 (2007) 931-939
22. Motlekar N.A., Srivenugopal K.S., Wachtel M.S., and Youan B.B. Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels. J. Drug Target. 13 (2005) 573-583
23. O K., Cheung F., Sung F.L., Zhu D.Y., and Siow Y.L. Effect of magnesium tanshinoate B on the production of nitric oxide in endothelial cells. Mol. Cell Biochem. 207 (2000) 35-39
24. O K., Lynn E.G., Vazhappilly R., Au-Yeung K.K., Zhu D.Y., and Siow Y.L. Magnesium tanshinoate B (MTB) inhibits low-density lipoprotein oxidation. Life Sci. 68 (2001) 903-912
25. Ouyang X.S., Takahashi K., Komatsu K., Nakamura N., Hattori M., Baba A., and Azuma J. Protective effects of Salvia miltiorrhiza on angiotensin II-induced hypertrophic responses in neonatal rat cardiac cells. Jpn. J. Pharmacol. 87 (2001) 289-296
26. Pan G.X., Zhang B.L., and Gao X.M. Determination of danshensu in rat serum after oral administer compound Salvia Recipe. Zhongguo Zhongyao Zazhi 28 (2003) 562-565
27. Pei W.J., Zhao X.F., Zhu Z.M., Lin C.Z., and Zhao W.M. Study of the determination and pharmacokinetics of compound Danshen Dripping Pill in human serum by column switching liquid chromatography electrospray ion trap mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 809 (2004) 237-242
28. Sakai M., Imai T., Ohtake H., Azuma H., and Otagiri M. Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy. J. Pharm. Sci. 86 (1997) 779-785
29. Sawada T., Ogawa T., Tomita M., Hayashi M., and Awazu S. Role of paracellular pathway in nonelectrolyte permeation across rat colon epithelium enhanced by sodium caprate and sodium caprylate. Pharm. Res. 8 (1991) 1365-1371
30. Scott-Moncrieff J.C., Shao Z., and Mitra A.K. Enhancement of intestinal insulin absorption by bile salt-fatty acid mixed micelles in dogs. J. Pharm. Sci. 83 (1994) 1465-1469
31. Shi Z.H., He J.T., Yao T.T., Chang W.B., and Zhao M.P. Simultaneous determination of cryptotanshinone, tanshinone I and tanshinone IIA in traditional Chinese medicinal preparations containing Radix salvia miltiorrhiza by HPLC. J. Pharm. Biomed. Anal. 37 (2005) 481-486
32. Takahashi K., Murakami T., Yumoto R., Hattori T., Higashi Y., and Yata N. Decanoic acid induced enhancement of rectal absorption of hydrophilic compounds in rats. Pharm. Res. 11 (1994) 1401-1404
33. Wang Y., Aun R., and Tse F.L. Absorption of d-glucose in the rat studied using in situ intestinal perfusion: a permeability-index approach. Pharm. Res. 14 (1997) 1563-1567
34. Ward P.D., Tippin T.K., and Thakker D.R. Enhancing paracellular permeability by modulating epithelial tight junctions. Pharm. Sci. Technol. Today 3 (2000) 346-358
35. Wei Y.J., Li S.L., and Li P. Simultaneous determination of seven active components of Fufang Danshen Tablet by high performance liquid chromatography. Biomed. Chromatogr. 21 (2007) 1-9
36. Wu Y.J., Hong C.Y., Lin S.J., Wu P., and Shiao M.S. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 481-486
37. Wu Y.T., Chen Y.F., Hsieh Y.J., Jaw I., Shiao M.S., and Tsai T.H. Bioavailability of salvianolic acid B in conscious and freely moving rats. Int. J. Pharm. 326 (2006) 25-31
38. Xiaohui Z., Xinfeng Z., Xin Z., Shixiang W., Yinmao W., and Jianbin Z. Determination of the main bioactive metabolites of Radix salvia miltiorrhizae in compound Danshen dripping pills and the tissue distribution of Danshensu in rabbit by SPE-HPLC-MSn. J. Sep. Sci. 30 (2007) 851-857
39. Yuan D., Pan Y.N., Fu W.W., Makino T., and Kano Y. Quantitative analysis of the marker compounds in Salvia miltiorrhiza root and its phytomedicinal preparations. Chem. Pharm. Bull. 53 (2005) 508-514
40. Zhang H., Yu C., Jia J.Y., Leung S., Siow Y.L., Man Y.K., and Zhu D.Y. Contents of four active components in different commercial crude drugs and preparations of Danshen (Salvia miltiorrhiza). Zhongguo Xinyao Zazhi 23 (2002) 1163-1168
41. Zhang J., Yu H., Sheng Y., Li L., Ye M., and Guo D. HPLC determination and pharmacokinetic studies of salvianolic acid B in rat plasma after oral administration of Radix Salvia Miltiorrhizae extract. Biomed. Chromatogr. 19 (2005) 15-18
42. Zhang L., Lin G., Chang Q., and Zuo Z. Role of intestinal first-pass metabolism of baicalein in its absorption process. Pharm. Res. 22 (2005) 1050-1058
43. Zhang L., Zheng Y., Chow M.S., and Zuo Z. Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model. Int. J. Pharm. 287 (2004) 1-12
44. Zhang Y., Akao T., Nakamura N., Duan C.L., Hattori M., Yang X.W., and Liu J.X. Extremely low bioavailability of magnesium lithospermate B, an active components from Salvia miltiorrhiza in rat. Planta Med. 70 (2004) 138-142
45. Zhang Y., Akao T., Nakamura N., Hattori M., Yang X.W., Duan C.L., and Liu J.X. Magnesium lithospermate B is excreted rapidly into rat bile mostly as methylated metabolites, which are potent antioxidants. Drug Metab. Dispos. 32 (2004) 752-757
46. Zhao B.L., Jiang W., Zhao Y., Hou J.W., and Xin W.J. Scavenging effects of Salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury. Biochem. Mol. Biol. Int. 38 (1996) 1171-1182
47. Zhou L., Chow M., and Zuo Z. Improved quality control method for Danshen products-consideration of both hydrophilic and lipophilic active components. J. Pharm. Biomed. Anal. 41 (2006) 744-750
48. Zhou L., Zuo Z., and Chow M.S. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J. Clin. Pharmacol. 45 (2005) 1345-1359